246 related articles for article (PubMed ID: 25848766)
1. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
Xiong Y; Wu S; Du Q; Wang A; Wang Z
Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
[TBL] [Abstract][Full Text] [Related]
4. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
9. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
10. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
11. Observation of significant biomarkers in osteosarcoma via integrating module- identification method with attract.
Qi J; Ma L; Wang X; Li Y; Wang K
Cancer Biomark; 2017 Jul; 20(1):87-93. PubMed ID: 28759958
[TBL] [Abstract][Full Text] [Related]
12. Personalized Identification of Differentially Expressed Modules in Osteosarcoma.
Liu X; Li C; Zhang L; Shi X; Wu S
Med Sci Monit; 2017 Feb; 23():774-779. PubMed ID: 28190021
[TBL] [Abstract][Full Text] [Related]
13. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
[TBL] [Abstract][Full Text] [Related]
14. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes in osteosarcoma by meta‑analysis of gene expression microarray.
Sun J; Xu H; Qi M; Zhang C; Shi J
Mol Med Rep; 2019 Oct; 20(4):3075-3084. PubMed ID: 31432118
[TBL] [Abstract][Full Text] [Related]
18. Investigating ego modules and pathways in osteosarcoma by integrating the EgoNet algorithm and pathway analysis.
Chen XY; Chen YH; Zhang LJ; Wang Y; Tong ZC
Braz J Med Biol Res; 2017 Feb; 50(2):e5793. PubMed ID: 28225867
[TBL] [Abstract][Full Text] [Related]
19. Identification of key biomarkers involved in osteosarcoma using altered modules.
Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
